While the ability of TGFβ to inhibit NK cell anti-tumor function is in line with this cytokine impact on other immune cells, TGFβ can also directly promote the conversion of NK cells into ILC1-like cells within a tumor environment. The gene discussed is TGFB1; the disease is neoplasm.